Meeting Banner
Abstract #1357

Deuterium metabolic imaging of a healthy human brain after oral glucose uptake on a clinical 3T MRI scanner

Michael Vaeggemose1,2, Rolf F. Schulte3, Christoffer Laustsen2, Esben Søvsø Szocska Hansen2, and Nikolaj Bøgh2
1GE Healtcare, Broendby, Denmark, 2MR Research Centre, Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark, 3GE Healtcare, Munich, Germany


Deuterium metabolic imaging (DMI) has emerged as a novel biomarker comparable to 18FDG PET by adding quantitative metabolic kinetic capabilities at high field (>3T). The main barrier for widespread clinical adoption, is the availability of high field clinical scanners. The aim of this study is to determine if DMI for neurological applications is feasible on a clinical 3T MRI scanner. Our findings suggests that it is indeed feasible, and that metabolic breakdown product (Glutamine/Glutamate) can be quantified around 120 min after ingestion.

This abstract and the presentation materials are available to members only; a login is required.

Join Here